Fact CheckerSign in

NCT07505602Recruiting

Air Purifier Use and Respiratory Health in COPD Patients

Respiratory Benefits of Indoor Air Purification in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 9 Jun 2026

Brief summary (registry, in English)

This randomized, double-blind, parallel-controlled trial aims to evaluate the effects of an indoor air purifier intervention on respiratory health in patients with Chronic Obstructive Pulmonary Disease (COPD).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
20 Mar 2026
Start date
30 Mar 2026
Primary completion date
Dec 2027
Lead sponsor
Fudan University
Diseases
COPD
NCT number
NCT07505602

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 30 Mar 2026 to the primary completion date, Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Subjects with a history of alcohol abuse
  • Subjects with other chronic lung diseases, such as active tuberculosis, pulmonary fibrosis, cystic fibrosis, or alpha-1 antitrypsin deficiency
  • Subjects with a history of thoracic surgery
  • Subjects with a history of malignant tumors, such as lung cancer, liver cancer, or gastric cancer
  • Subjects with diagnosed chronic hepatic or renal insufficiency, such as liver cirrhosis, chronic viral hepatitis, or autoimmune liver disease
  • Subjects with acute myocardial infarction or unstable arrhythmia diagnosed within the past 6 weeks

Other

  • Subjects living in a location other than home
  • Subjects currently participating in other interventional studies

Who the study is looking for

  • Age between 50 and 80 years old
  • Physician diagnosis of COPD
  • Living in Shanghai during the intervention period
  • Subjects who have no plans to change homes during the intervention period
  • Non-smokers and former smokers

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
School of Public Health, Fudan University
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.